Activation of β-adrenergic receptors increases the in vitro migration of malignant hepatocytes

Hepatology Research

Volumn 41, Issue 10, 2011, Pages 1000-1008

  Lodewyks, Carly ^a   Rodriguez, Jose F ^a   Yan, Jing ^a   Lerner, Betty ^a   Sun, Dongfeng ^a   Rempel, Julia D ^a   Uhanova, Julia ^a   Labine, Meaghan ^a   Minuk, Gerald Y ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Beta blocker; Hepatocellular carcinoma; Metastases; Migration; Noradrenaline; Proliferation

Indexed keywords

ADENYLATE CYCLASE; ALPHA 1 ADRENERGIC RECEPTOR; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; GELATINASE A; GELATINASE B; ISOPRENALINE; LABETALOL; MATRILYSIN; NORADRENALIN; PROTEIN KINASE C; STROMELYSIN;

ACCELERATION; ARTICLE; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; CELL STRAIN; CELL STRESS; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

EID: 80053241284     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2011.00854.x     Document Type: Article

References (28)

1. Riley V. Mouse mammary tumors: alteration of incidence as apparent function of stress. Science 1975; 189: 465-7.
2. Saul AN, Oberyszyn TM, Daugherty C etal. Chronic stress and susceptibility to skin cancer. J Natl Cancer Inst 2005; 7: 1760-7.
3. Wu W, Yamaura T, Murakami K etal. Social isolation stress enhanced liver metastasis of murine colon 26-l5 carcinoma cells by suppressing immune responses in mice. Life Sci 2000; 19: 1827-38.
4. Padgett DA, Glaser R. How stress influences the immune response. Trends Immunol 2003; 24: 444-8.
5. Sood AK, Bhatty R, Kamat AA etal. Stress hormone-mediated invasion of ovarian cancer cells. Clin Cancer Res 2006; 12: 369-75.
6. Yang EV, Sood AK, Chen M etal. Norepinephrine up-regulates the expression of vascular endothelial growth factor, matrix metalloproteinase (MMP)-2, and MMP-9 in nasopharyngeal carcinoma tumor cells. Cancer Res 2006; 66: 10357-64.
7. Drell TL, Joseph J, Lang K etal. Effects of neurotransmitters on the chemokinesis and chemotaxis of MDA-MB-468 human breast carcinoma cells. Breast Cancer Res Treat 2003; 80: 63-70.
8. Kassahun WT, Ungemach FR, Gottschalk J etal. Colorectal cancer metastases affect the biochemical characteristics of the human liver β-adrenoceptor-G-protein-adenylate cyclase system. Biochim Biophys Acta 2006; 1760: 259-66.
9. Yang EV, Donovan EL, Benson DM etal. VEGF is differentially regulated in multiple myeloma-derived cell lines by norepinephrine. Brain Behav Immun 2007; 22: 318-23.
10. Schuller HM, Al-Wadei HA, Majidi M. Gamma-aminobutyric acid, a potential tumor suppressor for small airway-derived lung adenocarcinoma. Carcinogenesis 2008; 29: 1979-85.
11. Palm D, Lang K, Niggemann B etal. The norepinephrine-driven metastasis development of PC-3 human prostate cancer cells in BALB/c nude mice is inhibited by β-blockers. Int J Cancer 2006; 118: 2744-9.
12. Masur K, Niggemann B, Zanker KS etal. Norepinephrine-induced migration of SW 480 colon carcinoma cells is inhibited by beta-blockers. Cancer Res 2001; 61: 2866-9.
13. Shang ZJ, Liu K, Liang F. Expression of beta2-adrenergic receptor in oral squamous cell carcinoma. J Oral Pathol Med 2009; 38: 371-6.
14. El-Serag HB. Hepatocellular carcinoma: recent trends in the United States. Gastroenterology 2004; 127: S27-S34.
15. Sherman M, Klein A. AASLD single-topic research conference on hepatocellular carcinoma: conference proceedings. Hepatology 2004; 40: 1465-73.
16. Befeler AS, Di Bisceglie AM. Hepatocellular carcinoma: diagnosis and treatment. Gastroenterology 2002; 122: 1609-19.
17. Di Bisceglie AM, Carithers RL, Gores GH. Hepatocellular carcinoma. Hepatology 1998; 27: 1161-5.
18. Nkontchou G, Mahmoudi A, Marty JR etal. Beta-blockers treatment is associated with a lower incidence of HCC in patients with viral C cirrhosis and oesophageal varices. Hepatology 2007; 46 (4). Abstract 381.
19. Yuan A, Li Z, Li X etal. The mitogenic effectors of isoproterenol in human hepatocellular carcinoma cells. Oncol Rep 2010; 23: 151-7.
20. Schuller HM, Al-Wadei HA. Neurotransmitter receptors as central regulators of pancreatic cancer. Future Oncol 2010; 6: 221-8.
21. B receptor is a novel drug target for pancreatic cancer. Cancer 2008; 112: 767-78.
22. Cortinovis C, Mayer D, Bouscarel B, Paris H, Murat JC. Study of beta-adrenoceptors and beta-adrenergic responsiveness in cultured "preneoplastic-like" and neoplastic rat hepatocytes. Gen Pharmacol 1985; 16: 259-63.
23. Garcia-Sainz JA, Alcantara R, Hernandez-Sotomayor SM, Mas-Oliva J. Beta 1-adrenoceptors in rat hepatoma. Desensitization by isoproterenol and phorbol-myristate-acetate. Life Sci 1989; 44: 1767-75.
24. Sanae F, Miyamoto K, Koshiura R. Altered adrenergic response and specificity of the receptors in rat ascites hepatoma AH130. Cancer Res 1989; 49: 624-6.
25. 1-adrenergic receptor stimulation of cell motility requires phospholipase D-mediated extracellular signal-regulated kinase activation. Chem Biol Drug Des 2007; 69: 240-50.
26. Chakroborty D, Sarkar C, Basu B etal. Catecholamines regulate tumor angiogenesis. Cancer Res 2009; 69: 3727-30.
27. Algazi M, Plu-Bureau G, Flahault A etal. Could treatments with β-blockers be associated with a reduction in cancer risk? Rev Epidemiol Sante Publique 2004; 52: 53-65.
28. Perron L, Bairati I, Harel F etal. Antihypertensive drug use and the risk of prostate cancer (Canada). Cancer Causes Control 2004; 15: 535-41.